Toll-Like Receptor 4: A Promising Therapeutic Target for Alzheimer’s Disease
Alzheimer’s disease (AD) is a progressive neurodegenerative disease that primarily manifests as memory deficits and cognitive impairment and has created health challenges for patients and society. In AD, amyloid β-protein (Aβ) induces Toll-like receptor 4 (TLR4) activation in microglia. Activation o...
Saved in:
Main Authors: | Linyu Wu, Xiaohui Xian, Guangyu Xu, Zixuan Tan, Fang Dong, Min Zhang, Feng Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2022/7924199 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Targeting Toll-Like Receptors for Treatment of SLE
by: Christopher G. Horton, et al.
Published: (2010-01-01) -
Toll-Like Receptor Signaling Pathways—Therapeutic Opportunities
by: Jiankun Zhu, et al.
Published: (2010-01-01) -
Toll-like receptors in atopic dermatitis: pathogenesis and therapeutic implications
by: Ahmad Vafaeian, et al.
Published: (2025-02-01) -
Modulation of Toll-Like Receptor Signalling as a New Therapeutic Principle
by: Philipp M. Lepper, et al.
Published: (2010-01-01) -
Association of Toll-Like Receptor Signaling and Reactive Oxygen Species: A Potential Therapeutic Target for Posttrauma Acute Lung Injury
by: Meng Xiang, et al.
Published: (2010-01-01)